 |
인쇄하기
취소
|
SK, IVI sign MOU deal to develop typhoid vaccine
SK Chemicals announced Monday that it has signed a memorandum of understanding (MOU) with International Vaccine Institute to collaborate on typhoid vaccine development and supply.
The collaboration will focus on the establishment of a global vaccine system to protect children from the risk of typhoid fever in developing countries.
Under the deal, SK and IVI will exchange their technology...
The collaboration will focus on the establishment of a global vaccine system to protect children from the risk of typhoid fever in developing countries.
Under the deal, SK and IVI will exchange their technology...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.